360 related articles for article (PubMed ID: 28706126)
1. Transfemoral Transcatheter Aortic Valve-in-Valve Implantation for Aortic Valve Bioprosthesis Failure With the Fully Repositionable and Retrievable Lotus Valve: A Single-Center Experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
J Invasive Cardiol; 2017 Sep; 29(9):315-319. PubMed ID: 28706126
[TBL] [Abstract][Full Text] [Related]
2. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
[TBL] [Abstract][Full Text] [Related]
3. Redo procedures for degenerated stentless aortic xenografts and the role of valve-in-valve transcatheter techniques.
Grubitzsch H; Zobel S; Christ T; Holinski S; Stangl K; Treskatsch S; Falk V; Laule M
Eur J Cardiothorac Surg; 2017 Apr; 51(4):653-659. PubMed ID: 28062549
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
5. First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.
Schaefer A; Harmel E; Seiffert M; Reichart D; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
Interact Cardiovasc Thorac Surg; 2017 May; 24(5):659-662. PubMed ID: 28329312
[TBL] [Abstract][Full Text] [Related]
6. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
7. Valve-in-valve transcatheter aortic valve implantation for failing surgical aortic stentless bioprosthetic valves: A single-center experience.
Duncan A; Davies S; Di Mario C; Moat N
J Thorac Cardiovasc Surg; 2015 Jul; 150(1):91-8. PubMed ID: 25869089
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of Transcatheter Valve-in-Valve Implantation Versus Redo Aortic Valve Surgery for Bioprosthetic Aortic Valve Dysfunction.
Neupane S; Singh H; Lämmer J; Othman H; Yamasaki H; Rosman HS; Bossone E; Mehta RH; Eggebrecht H
Am J Cardiol; 2018 Jun; 121(12):1593-1600. PubMed ID: 29776652
[TBL] [Abstract][Full Text] [Related]
9. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
10. First North American experience with the transfemoral ACURATE-neo
Bagur R; Teefy PJ; Kiaii B; Diamantouros P; Chu MWA
Catheter Cardiovasc Interv; 2017 Jul; 90(1):130-138. PubMed ID: 27677241
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
[TBL] [Abstract][Full Text] [Related]
12. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
13. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter aortic valve-in-valve implantation: clinical outcome as defined by VARC-2 and postprocedural valve dysfunction according to the primary mode of bioprosthesis failure.
Stähli BE; Reinthaler M; Nguyen-Kim TD; Gebhard C; Tasnady H; Grünenfelder J; Falk V; Corti R; Frauenfelder T; Lüscher TF; Maier W; Mullen MJ; Landmesser U
J Invasive Cardiol; 2014 Oct; 26(10):542-7. PubMed ID: 25274865
[TBL] [Abstract][Full Text] [Related]
15. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic Performances and Clinical Outcomes in Patients Undergoing Valve-in-Valve Versus Native Transcatheter Aortic Valve Implantation.
Akodad M; Meilhac A; Lefèvre T; Cayla G; Lattuca B; Autissier C; Duflos C; Gandet T; Macia JC; Delseny D; Roubille F; Maupas E; Schmutz L; Piot C; Targosz F; Robert G; Rivalland F; Albat B; Chevalier B; Leclercq F
Am J Cardiol; 2019 Jul; 124(1):90-97. PubMed ID: 31076081
[TBL] [Abstract][Full Text] [Related]
17. Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System.
Jarr KU; Leuschner F; Meder B; Katus HA; Bekeredjian R; Chorianopoulos E
J Invasive Cardiol; 2017 Jan; 29(1):30-35. PubMed ID: 27845874
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registry.
De Backer O; Götberg M; Ihlberg L; Packer E; Savontaus M; Nielsen NE; Jørgensen TH; Nykänen A; Baranowski J; Niemelä M; Eskola M; Bjursten H; Søndergaard L
Int J Cardiol; 2016 Sep; 219():92-7. PubMed ID: 27288972
[TBL] [Abstract][Full Text] [Related]
19. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.
Eggebrecht H; Schäfer U; Treede H; Boekstegers P; Babin-Ebell J; Ferrari M; Möllmann H; Baumgartner H; Carrel T; Kahlert P; Lange P; Walther T; Erbel R; Mehta RH; Thielmann M
JACC Cardiovasc Interv; 2011 Nov; 4(11):1218-27. PubMed ID: 22115663
[TBL] [Abstract][Full Text] [Related]
20. Severe structural deterioration of small aortic bioprostheses treated with valve-in-valve transcatheter aortic valve implantation.
Stankowski T; Aboul-Hassan SS; Seifi-Zinab F; Herwig V; Kubikova M; Harnath A; Fritzsche D; Perek B
J Card Surg; 2019 Jan; 34(1):7-13. PubMed ID: 30625244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
